首页> 外文期刊>American pharmaceutical review >Advancing to Recombinant Heparin
【24h】

Advancing to Recombinant Heparin

机译:Advancing to Recombinant Heparin

获取原文
获取原文并翻译 | 示例
           

摘要

Heparin is a potent anticoagulant that has been used clinically to manage blood clotting since 1935. Hundreds of thousands of doses are administered daily in the U.S. during surgery and for patients at risk of venous thromboembolism. Medical devices that come in contact with blood, such as dialysis tubing, are also coated with heparin. The importance of heparin is underscored by its inclusion on the World Health Organization's list of essential medicines and a worldwide market of over $7B annually.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号